ArticleMolecular oncology2025
Targeting the CLK2/SRSF9 splicing axis in prostate cancer leads to decreased ARV7 expression.
Jasper Van Goubergen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it